Irina Antonijevic - May 11, 2022 Form 4 Insider Report for Biohaven Pharmaceutical Holding Co Ltd. (BHVN)

Role
Director
Signature
/s/ George Clark, Attorney-in-Fact
Stock symbol
BHVN
Transactions as of
May 11, 2022
Transactions value $
$0
Form type
4
Date filed
5/12/2022, 08:57 PM
Previous filing
May 11, 2022
Next filing
Sep 30, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BHVN Restricted Share Unit Award Award $0 +5.07K $0.00 5.07K May 11, 2022 Common Shares 5.07K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted share unit represents the contingent right to receive one common share of the issuer.
F2 The reporting person was granted 5,070 restricted share units on May 11, 2022, vesting in four equal installments on May 11, 2022, 2023, 2024 and 2025 subject to the reporting person's continued service with the issuer at each vesting date.
F3 Not applicable.